Join Vijay Pande, a16z bio fund general partner, Jeff Kindler, former Pfizer CEO, and Andrew Radin, CEO of TwoXAR, as they dissect the intersection of computation and biology. They discuss how the mindset of 'move fast' contrasts with the slow pharmaceutical landscape. Discover how cloud computing and big data revolutionize drug development, the challenges of data sharing, and the role of AI in making healthcare more affordable. The future of healthcare relies on robust data and innovative thinking!
